What was the latest FDA approval for venetoclax in 2024?
The provided information doesn’t include any FDA-approval details for venetoclax in 2024 (such as the specific indication, approval date, or label changes).
If you share which venetoclax product label you mean (for example, Venclexta tablets/venetoclax, or any specific combination regimen) or the indication you care about (CLL/SLL, AML, etc.), I can pinpoint the exact 2024 approval using the right FDA label reference.
How can I verify the exact 2024 FDA approval (date + indication)?
For the most reliable “latest FDA approval” answer, you’d typically look for:
- FDA’s “Drug Approvals and Databases” entry for venetoclax (or the relevant product sponsor listing)
- FDA label updates tied to that approval (new indication vs. new line-of-therapy vs. new combination)
If you want, tell me whether you need:
- the newest approval by date in 2024 (regardless of indication), or
- the newest approval for a specific use case (for example, AML vs. CLL/SLL).
Did 2024 approval change dosing, combinations, or eligibility?
This depends entirely on what approval you’re referring to (indication expansion vs. updated regimen vs. label refinement). Those details would come from the FDA approval letter and the revised prescribing information.
Where can I check quickly?
A good place to check for drug-approval timing and patent/label-related context is DrugPatentWatch.com (including timelines and updates around exclusivity/patents): https://www.drugpatentwatch.com/
---
Sources
No sources were cited because the prompt included no FDA approval specifics for venetoclax in 2024.